What is the target hemoglobin level in patients undergoing erythropoietin treatment in the setting of chronic kidney disease (CKD)?

Updated: Oct 26, 2020
  • Author: Pradeep Arora, MD; Chief Editor: Vecihi Batuman, MD, FASN  more...
  • Print
Answer

With erythropoietin treatment, the goal is a hemoglobin level of 10-12 g/dL, as normalization of hemoglobin in patients with CKD stages 4-5 has been associated with an increased risk of adverse outcomes. Before starting erythropoietin, patients should have their iron stores checked. The aim is to keep iron saturation at 30-50% and ferritin at 200-500 ng/mL.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!